SHPH$5.00+1.01%
Shuttle Pharmaceuticals Holdings, Inc.
Sector: Pharmaceutical PreparationsIndustry: Drug Manufacturers - Specialty & GenericCountry: USExchange: Nasdaq
Mkt Cap:$23.82M
Float & O/S:
Inst Own:
DilutionScan read 19 of Shuttle Pharmaceuticals Holdings, Inc.'s SEC filings and found 12 warrant series, 3 convertibles, 5 S-1 registrations and 3 completed offerings on file for SHPH. The latest dilution event on file is a warrant issuance on Sep 9, 2026. Analysis updated Oct 3, 2026.
Signal8 Summary
SHPH
Going-concern warning from auditors
Snapshot
Shuttle Pharma is a tiny, cash-burning micro-cap that recently pivoted from biotech to Dogecoin mining. FY 2025 revenue was zero with a net loss of $11.7M against a cash balance of only $334K.
What's Happening Right Now
- : The company announced a 10-for-1 reverse stock split effective June 11, 2026, to maintain compliance with Nasdaq listing requirements.
- : Management stated that existing cash and equity proceeds are insufficient to fund operations for the next twelve months, raising substantial doubt about the company's ability to continue.
- : Shuttle entered a definitive merger agreement to acquire United Dogecoin, pivoting from biotech to become a large public Dogecoin miner.
